🏛️ Verified NIH Record • Updated 2025-06-03
Cardiogenic Shock Working Group Registry (NCT04682483)
🟢 Recruiting Interventional Protocol 📊 Observational Clinical Research Sponsor: Tufts Medical Center
🩺 Plain-English Summary (8th-Grade Level)
The Cardiogenic Shock Working Group is a multicenter registry where we collect de-identified clinical variables from the medical records and follow-up phone calls of shock patients from multiple institutions and centralize this data to a single registry for analysis of clinical outcomes.
Who can join: Review the eligibility criteria below.
Location: Cleveland Clinic Florida — Weston, Florida
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (16 Sites)
- Cleveland Clinic Florida — Weston, Florida
- Northwestern Medicine — Chicago, Illinois
- University of Chicago — Chicago, Illinois
- Maine Medical Center — Portland, Maine
- Tufts Medical Center — Boston, Massachusetts
- Beth Israel Deaconess Medical Center — Boston, Massachusetts
- Hackensack Meridian Health — Hackensack, New Jersey
- Columbia University Irving Medical Center — New York, New York
- Providence St. Vincent Heart Clinic — Portland, Oregon
- Allegheny General Hospital — Pittsburgh, Pennsylvania
- University Of Pittsburgh Medical Center — Pittsburgh, Pennsylvania
- Baylor Scott & White Advanced Heart Failure Clinic — Dallas, Texas
- University of Texas Medical Branch — Galveston, Texas
- Houston Methodist Hospital — Houston, Texas
- Inova Health System — Falls Church, Virginia
- University of Washington Medical Center — Seattle, Washington
📞 Contact the Study Coordinator
Phone: (617) 636-8252
Email: nkapur@tuftsmedicalcenter.org
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Cardiogenic Shock
- A Safety and Efficacy Trial of Istaroxime for Cardiogenic Shock Stage C — Boston, Massachusetts
- Augmented Pacing for Shock in the Cardiac Intensive Care Unit — Nashville, Tennessee
- Can Escalation Reduce Acute Myocardial Infarction Mortality in Cardiogenic Shock — Loma Linda, California
- CORTISHOCK-P: Trial of Corticosteroids in Inflammation-Enriched Heart Failure Cardiogenic Shock — Boston, Massachusetts
- Intra-aortic Balloon Counterpulsation (IABC) Compliance — Philadelphia, Pennsylvania
- Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial — Falls Church, Virginia
Explore by condition: All Cardiogenic Shock clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.